ArticleApoptosis : an international journal on programmed cell death2026
Silencing SLC52A2 promotes tertiary lymphoid structure formation and inhibits IL-17 pathway to ameliorate melanoma progression.
Linxue Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.